275 related articles for article (PubMed ID: 17320796)
21. Autoimmune hepatitis: evolving concepts.
Diamantis I; Boumpas DT
Autoimmun Rev; 2004 Mar; 3(3):207-14. PubMed ID: 15110233
[TBL] [Abstract][Full Text] [Related]
22. De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis.
Yoshizawa K; Shirakawa H; Ichijo T; Umemura T; Tanaka E; Kiyosawa K; Imagawa E; Matsuda K; Hidaka E; Sano K; Nakazawa Y; Ikegami T; Hashikura Y; Miyagawa S; Ota M; Nakano M
Clin Transplant; 2008; 22(3):385-90. PubMed ID: 18190552
[TBL] [Abstract][Full Text] [Related]
23. Animal models of autoimmune hepatitis.
Jaeckel E
Semin Liver Dis; 2002 Nov; 22(4):325-38. PubMed ID: 12447705
[TBL] [Abstract][Full Text] [Related]
24. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
25. Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation.
Inui A; Sogo T; Komatsu H; Miyakawa H; Fujisawa T
Liver Transpl; 2005 May; 11(5):504-7. PubMed ID: 15838910
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune liver disease.
Czaja AJ
Curr Opin Gastroenterol; 2006 May; 22(3):234-40. PubMed ID: 16550037
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis in liver diseases--detection and therapeutic applications.
Ghavami S; Hashemi M; Kadkhoda K; Alavian SM; Bay GH; Los M
Med Sci Monit; 2005 Nov; 11(11):RA337-45. PubMed ID: 16258409
[TBL] [Abstract][Full Text] [Related]
28. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.
Czaja AJ; Manns MP
Gastroenterology; 2010 Jul; 139(1):58-72.e4. PubMed ID: 20451521
[TBL] [Abstract][Full Text] [Related]
29. Immunohistopathological reactions for liver-specific membrane lipo-protein in experimental autoimmune hepatitis.
Chattopadhyay D; Sen MR; Aryya NC
Indian J Pathol Microbiol; 1999 Jul; 42(3):291-7. PubMed ID: 10862286
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis viruses: live and let die.
Herzer K; Sprinzl MF; Galle PR
Liver Int; 2007 Apr; 27(3):293-301. PubMed ID: 17355449
[TBL] [Abstract][Full Text] [Related]
31. Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis.
Warren A; Bertolino P; Benseler V; Fraser R; McCaughan GW; Le Couteur DG
J Hepatol; 2007 Feb; 46(2):239-46. PubMed ID: 17125874
[TBL] [Abstract][Full Text] [Related]
32. Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis.
Mochida S; Yoshimoto T; Mimura S; Inao M; Matsui A; Ohno A; Koh H; Saitoh E; Nagoshi S; Fujiwara K
Biochem Biophys Res Commun; 2004 Apr; 317(1):114-20. PubMed ID: 15047155
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis and treatment of autoimmune hepatitis and chronic viral hepatitis B and C.
Pár A
Acta Physiol Hung; 2000; 87(4):373-95. PubMed ID: 11732890
[TBL] [Abstract][Full Text] [Related]
34. The benefit of animal models for autoimmune hepatitis.
Jaeckel E; Hardtke-Wolenski M; Fischer K
Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):643-51. PubMed ID: 22117631
[TBL] [Abstract][Full Text] [Related]
35. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.
Biburger M; Tiegs G
J Leukoc Biol; 2008 Jul; 84(1):264-79. PubMed ID: 18407967
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune hepatitis. Part A: pathogenesis.
Czaja AJ
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):113-28. PubMed ID: 19072440
[TBL] [Abstract][Full Text] [Related]
37. Evolving concepts in the diagnosis, pathogenesis and treatment of autoimmune hepatitis.
Czaja AJ
Minerva Gastroenterol Dietol; 2007 Mar; 53(1):43-78. PubMed ID: 17415344
[TBL] [Abstract][Full Text] [Related]
38. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune liver disease and rheumatic manifestations.
Czaja AJ
Curr Opin Rheumatol; 2007 Jan; 19(1):74-80. PubMed ID: 17143100
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune Hepatitis and PSC Connection.
Vergani D; Mieli-Vergani G
Clin Liver Dis; 2008 Feb; 12(1):187-202, x. PubMed ID: 18242504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
